$530M
$9.53 Million
0.0% of portfolio
837
Q2 2025
Reduced 29.07%
$844M
$9.54 Million
0.0% of portfolio
2,665
Q1 2025
Reduced 58.33%
$327M
$9.56 Million
0.0% of portfolio
487
Q2 2025
Reduced 29.42%
$9.05B
$9.57 Million
0.0% of portfolio
30
Q2 2025
Added 20.0%
$0
$9.57 Million
0.0% of portfolio
105
Q1 2025
Reduced 98.85%
$3.46B
$9.57 Million
0.0% of portfolio
342
Q2 2025
Added 21.71%
$371M
$9.58 Million
0.0% of portfolio
194
Q2 2025
Reduced 29.45%
$1.05B
$9.6 Million
0.0% of portfolio
359
Q2 2025
Added 385.14%
$266M
$9.62 Million
0.0% of portfolio
288
Q2 2025
Added 123.26%
$2.62B
$9.62 Million
0.0% of portfolio
167
Q2 2025
Added 51.82%
$1.78B
$9.69 Million
0.0% of portfolio
220
Q2 2025
Reduced 61.4%
$876M
$9.7 Million
0.0% of portfolio
692
Q2 2025
Reduced 30.24%
$1.03B
$9.79 Million
0.0% of portfolio
2,069
Q2 2025
Reduced 69.12%
$244M
$9.81 Million
0.0% of portfolio
1,552
Q2 2025
Added 69.43%
$356M
$9.82 Million
0.0% of portfolio
1,043
Q2 2025
Reduced 44.84%
$276M
$9.84 Million
0.0% of portfolio
431
Q2 2025
Added 498.61%
$452M
$9.89 Million
0.0% of portfolio
313
Q2 2025
Added 17.23%
$1.64B
$9.89 Million
0.0% of portfolio
344
Q2 2025
Added 70.3%
Nebius Group Nv Shs Class A
-
$9.9 Million
0.0% of portfolio
-
Q1 2025
Reduced 95.26%
$522M
$9.93 Million
0.0% of portfolio
627
Q2 2025
Added 25.65%
$367M
$9.94 Million
0.0% of portfolio
232
Q2 2025
Reduced 53.69%
$1.69B
$9.94 Million
0.0% of portfolio
1,358
Q2 2025
Added 9.43%
$0
$9.96 Million
0.0% of portfolio
66
Q1 2025
Reduced 99.27%
$381M
$9.97 Million
0.0% of portfolio
429
Q2 2025
Added 52.67%
Structure Therapeutics Inc Sponsored Ads
-
$9.98 Million
0.0% of portfolio
-
Q2 2025
Reduced 5.13%
$0
$9.99 Million
0.0% of portfolio
190
Q1 2025
Reduced 98.04%
$222M
$10 Million
0.0% of portfolio
897
Q2 2025
Reduced 36.02%
$288M
$10 Million
0.0% of portfolio
-
Q2 2025
Added 875.0%
$1.41B
$10.1 Million
0.0% of portfolio
234
Q2 2025
Added 91.8%
$1.03B
$10.1 Million
0.0% of portfolio
621
Q2 2025
Reduced 17.31%
-
$10.1 Million
0.0% of portfolio
-
Q2 2025
Added 6.9%
$14.8B
$10.2 Million
0.0% of portfolio
303
Q1 2025
Reduced 96.64%
$0
$10.2 Million
0.0% of portfolio
208
Q2 2025
New
$759M
$10.2 Million
0.0% of portfolio
219
Q2 2025
Reduced 57.88%
-
$10.2 Million
0.0% of portfolio
-
Q2 2025
Added 49.17%
$375M
$10.2 Million
0.0% of portfolio
856
Q2 2025
Reduced 54.78%
$977M
$10.2 Million
0.0% of portfolio
334
Q2 2025
Added 41.53%
$835M
$10.2 Million
0.0% of portfolio
825
Q2 2025
Added 30.74%
$2.01B
$10.2 Million
0.0% of portfolio
957
Q2 2025
Reduced 71.37%
-
$10.2 Million
0.0% of portfolio
-
Q2 2025
Added 175.44%
$603M
$10.3 Million
0.0% of portfolio
878
Q2 2025
Reduced 53.45%
$664M
$10.3 Million
0.0% of portfolio
344
Q2 2025
Added 8.86%
$2.68B
$10.3 Million
0.0% of portfolio
663
Q2 2025
Reduced 1.63%
$0
$10.3 Million
0.0% of portfolio
150
Q2 2025
New
$523M
$10.3 Million
0.0% of portfolio
188
Q2 2025
Added 113.64%
$2.13B
$10.3 Million
0.0% of portfolio
525
Q2 2025
Added 60.55%
Biodexa Pharmaceuticals PLC Sponsored Ads
-
$10.3 Million
0.0% of portfolio
-
Q2 2025
Added 737.31%
$248M
$10.3 Million
0.0% of portfolio
1,488
Q2 2025
Added 40.64%
$740M
$10.3 Million
0.0% of portfolio
176
Q2 2025
Added 61.47%
$906M
$10.4 Million
0.0% of portfolio
518
Q2 2025
Reduced 4.07%